Thomas Ebeling - 10 Jun 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Director
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
10 Jun 2024
Net transactions value
+$239,850
Form type
4
Filing time
11 Jun 2024, 18:00:03 UTC
Previous filing
23 May 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Options Exercise $239,850 +18,450 +11% $13.00 186,653 10 Jun 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGEM Stock Option (Right to Buy) Options Exercise $0 -18,450 -100% $0.000000* 0 10 Jun 2024 Common Stock 18,450 $13.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.